6594 Phase II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patientsC. Morizane,T. Okusaka,M. Ikeda,J. Furuse,S. Ohkawa,K. Nakachi,E. Suzuki,M. UenoEJC SUPPLEMENTS(2009)引用 10|浏览11暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要